Monthly Prescribing Reference

FDA Considers Mail-Back Envelope as New Disposal Method for Opioids

The Agency is currently seeking public comment on this potential modification to the existing Opioid Analgesic Risk Evaluation and Mitigation Strategy. In an effort to reduce unnecessary exposure to ...
Monthly Prescribing Reference

FDA Requires Manufacturers to Provide Mail-Back Envelopes for Opioid Disposal

Credit: Getty Images. Approval of the modified Opioid Analgesic REMS is expected in 2024. To promote the safe disposal of unused opioid medications, the Food and Drug Administration (FDA) is requiring ...
JD Supra

FDA May Require Opioids to be Dispensed with Mail-Back Envelopes and Related Patient Education

The FDA is requesting public comments on a possible change to the Opioid Analgesic Risk Evaluation and Mitigation Strategy requiring opioid analgesics (OA) used in an outpatient setting to be ...
RAPS

FDA to require mail-back envelopes for unused opioids

Drugmakers will soon have to provide patients with postage-paid envelopes to send back unused opioids for safe disposal under a new requirement announced by the US Food and Drug Administration (FDA) ...